Information from Industry is developed under the direction and sponsorship of our industry partners, as noted in each episode. Medscape editorial had no part in the creation of these episodes, and each industry partner is solely responsible for the content of the applicable episode. This podcast is intended for healthcare professionals in the United States only.
Information from Industry
Claim This Podcastby Medscape
4 episodes
Updated Bi-weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
12
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement0
Podcast Overview
Information from Industry is developed under the direction and sponsorship of our industry partners, as noted in each episode. Medscape editorial had no part in the creation of these episodes, and each industry partner is solely responsible for the content of the applicable episode. This podcast is intended for healthcare professionals in the United States only.
Language
🇺🇲
Publishing Since
7/8/2024
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
12
Podcast Authority
BetaPoorBased on show quality, social media presence, reviews, charts, and more
Quality25
Social0
YouTube0
Engagement0
6
Excellent Areas
2
Good Performance
11
Growth Opportunities
excellent
Episode Length
8 minutes
Performing excellently!
good
Show Notes Quality
3.0/5
Recommendations available
Unlock the full report to see detailed tips
poor
Publishing Consistency
Every 53 days
Recommendations available
Unlock the full report to see detailed tips
+16 More Metrics
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
What's Included in Your Full Report
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
Get your free podcast insights report
See how your show performs across every key metric
Instant delivery
No spam
Attract Better Guests
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Secure Sponsorships
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Grow Your Audience
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Information from Industry
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 7, 2025
Interview with Dr. Krishna, Episode 3: The present and future of CVD management
<div class="page" title="Page 3"> <div class="layoutArea"> <div class="column"> <p>Are you treating patients with cardiovascular disease? Hear tips for disease management, with discussion of a treatment option. Dr. Vamsi Krishna discusses his patients’ experiences with CVD. The scope of CVD in the US is overwhelming, but he argues we have more power over it than we think. Relevant disclosures, transcript, and more can be found on Medscape (https://www.medscape.com/brandplay/338730.1).</p> <p>Abbreviations:</p> <p>ASCVD, atherosclerotic cardiovascular disease; AHA, American Heart Association; CV, cardiovascular; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; US, United States.</p> <p>References:<br /> 1. Martin SS, et al. Circulation. 2024;149:e347-e913.<br /> 2. Oppenheimer GM. Int J Epidemiol. 2006;35:720-730.<br /> 3. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.<br /> 4. Magnussen C, et al. N Engl J Med. 2023;389:1273-85.<br /> 5. Gu J, et al. Am J Prev Cardiol. 2022;10:100336.<br /> 6. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418. 7. Makover ME, et al. Am J Prev Cardiol. 2022;12:100371.<br /> 8. Product Prescribing Information.<br /> 9. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.<br /> 10. O'Donoghue ML, et al. Circulation. 2022;146:1109-1119.</p> </div> </div> </div>
February 7, 2025
Interview with Dr. Krishna, Episode 2: Overcoming barriers to ASCVD treatment
<div class="page" title="Page 2"> <div class="layoutArea"> <div class="column"> <p>Are you treating patients with cardiovascular disease? Hear tips for disease management. Dr. Vamsi Krishna presents clinical data for a treatment option. Additional considerations include common barriers to treatment. Relevant disclosures, transcript, and more can be found on Medscape (<a href= "https://www.medscape.com/brandplay/338730.1)">https://www.medscape.com/brandplay/338730.1)</a>.</p> <div class="page" title="Page 2"> <div class="layoutArea"> <div class="column"> <p>Abbreviations:</p> <p>ACC, American College of Cardiology; ASCVD, atherosclerotic cardiovascular disease; ACS, acute coronary syndrome; CHF, congestive heart failure; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PAD, peripheral artery disease; US, United States; VHR, very high risk.</p> <p>References:<br /> 1. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.<br /> 2. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418.<br /> 3. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.<br /> 4. Data on file, Amgen; 2022.<br /> 5. O'Donoghue ML, et al. Circulation. 2022;146:1109-1119.<br /> 6. Product Prescribing Information.<br /> 7. MacDougall DE, et al. Circ Cardiovasc Qual Outcomes. 2024;17:e009988.</p> <p>8. Data on file, Amgen; 2024.</p> <p>9. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a615043.html. Accessed July 1, 2024.</p> </div> </div> </div> </div> </div> </div>
February 7, 2025
Interview with Dr. Krishna, Episode 1: LDL-C and management of ASCVD
<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>Are you treating patients with cardiovascular disease? Hear tips for disease management from Dr. Vamsi Krishna, an Assistant Professor at The University of Texas at Austin Dell Medical School and an Interventional Cardiologist and Endovascular Medicine Physician at the Ascension Seton Heart Institute, where he is the Medical Director of both the Cardiac Catheterization Lab and the Cardiac Rehabilitation Center. Dr. Krishna covers key aspects of ASCVD management for your patient – most critically LDL-C lowering, including discussion of a treatment option. Relevant disclosures, transcript, and more can be found on Medscape (<a href= "https://www.medscape.com/brandplay/338730.1)">https://www.medscape.com/brandplay/338730.1)</a>.</p> <div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>Abbreviations:</p> <p>ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; CV, cardiovascular; IS, ischemic stroke; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; non-HDL-C, non- high-density lipoprotein; PAD, peripheral artery disease; US, United States.</p> <p>References:</p> <p>1. National Library of Medicine. https://medlineplus.gov/ency/patientinstructions/000759.htm. Accessed July 1, 2024.</p> </div> </div> <div class="layoutArea"> <div class="column"> <p>2. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.<br /> 3. Spertus J, et al. J Am Coll Cardiol. 2018;71(suppl 11):A24.<br /> 4. Muntner P, et al. Cardiovasc Drugs Ther. 2022;36:475-481.<br /> 5. Fonarow GC, et al. Clin Cardiol. 2021;44:1327-1481.<br /> 6. Grundy SM, et al. J Am Coll Cardiol. 2019;73:e285-e350.<br /> 7. Amgen. News release; July 11, 2016.<br /> 8. Zhang J, et al. Front Nutr. 2023;9:1044329.<br /> 9. Stitziel NO, et al. Trends Mol Med. 2020;26:744-757.<br /> 10. Lee M, et al. JAMA Neurol. 2022;79(4):349-358.<br /> 11. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.<br /> 12. Sniderman AD, et al. Circ Cardiovasc Qual Outcomes. 2011;4:337-345. 13. Data on file, Amgen; 2023.<br /> 14. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418.<br /> 15. Paul B, et al. JHEP Rep. 2022;4:100479.</p> </div> </div> </div> </div> </div> </div>
4 total episodes available
Deep-dive analytics for Information from Industry
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Information from Industry?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.